STOCKHOLDERS' EQUITY (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 26, 2018 |
May 15, 2018 |
Apr. 24, 2018 |
Apr. 19, 2018 |
Apr. 02, 2018 |
Aug. 24, 2017 |
Jul. 19, 2017 |
Jul. 14, 2017 |
Jul. 13, 2017 |
Dec. 06, 2016 |
Sep. 22, 2016 |
Jul. 31, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Apr. 04, 2018 |
Aug. 21, 2017 |
Sep. 30, 2016 |
Apr. 05, 2016 |
Mar. 26, 2013 |
Dec. 10, 2012 |
Mar. 22, 2012 |
Aug. 03, 2006 |
|
| Common stock authorized | 250,000,000 | 500,000,000 | ||||||||||||||||||||
| Common stock outstanding | 7,407,254 | 4,299,311 | ||||||||||||||||||||
| Number of options outstanding | 803,937 | 554,083 | 223,120 | |||||||||||||||||||
| Common stock exercise price (in dollars per share) | $ 10.13 | $ 16.14 | $ 50.98 | |||||||||||||||||||
| Number of stock options granted | 468,000 | 334,000 | ||||||||||||||||||||
| Total unrecognized stock-based compensation | $ 185,537 | $ 1,066,773 | ||||||||||||||||||||
| Number of vested shares | 531,604 | 249,284 | ||||||||||||||||||||
| Number of unvested shares | 272,333 | 304,799 | ||||||||||||||||||||
| Gross cash proceeds | $ 930,435 | $ 2,981,300 | ||||||||||||||||||||
| Shares issued price per share (in dollars per share) | $ 5.90 | |||||||||||||||||||||
| Restricted Stock [Member] | ||||||||||||||||||||||
| Number of equity instruments other than options outstanding | 406,564 | 222,750 | 143,750 | |||||||||||||||||||
| Total unrecognized stock-based compensation | $ 59,028 | $ 205,858 | ||||||||||||||||||||
| Number of shares granted under the plan | 183,814 | 79,000 | ||||||||||||||||||||
| Stock Option [Member] | ||||||||||||||||||||||
| Total unrecognized stock-based compensation | $ 126,509 | $ 860,915 | ||||||||||||||||||||
| 2006 Stock Incentive Plan [Member] | ||||||||||||||||||||||
| Common stock outstanding | 1,445 | |||||||||||||||||||||
| Number of shares reserved for future issuance | 3,339 | |||||||||||||||||||||
| Omnibus Incentive Compensation Plan 2012 [Member] | ||||||||||||||||||||||
| Common stock purchase price (in dollars per share) | $ 0.001 | |||||||||||||||||||||
| Common stock authorized | 975,000 | |||||||||||||||||||||
| Weighted exercise price of awarded shares (in dollars per share) | $ 4.39 | |||||||||||||||||||||
| Number of options outstanding | 802,492 | |||||||||||||||||||||
| Number of options authorized | 200,000 | 75,000 | 27,500 | 1,667 | ||||||||||||||||||
| Number of authorized shares available for grant previously | 885,781 | |||||||||||||||||||||
| Number of authorized shares available for grant | 1,570,248 | |||||||||||||||||||||
| Maximum number of shares granted to individual | 150,000 | |||||||||||||||||||||
| Description of plan terms | The holders of the Company's common and preferred stock voted to (i) amend the 2012 Plan to eliminate the annual individual award limits under the 2012 Plan and (ii) amend 2012 Plan to increase: (a) the total number of shares of common stock, par value $0.001 per share (“Common Stock”), available for grant under the 2012 Plan (subject to the overall limits described in clause (b) below) from 1,500,000 shares to an aggregate of 2,250,000 shares and (b) the aggregate limitation on authorized shares available for grant under the 2012 Plan, following any increases pursuant to the evergreen provision (the “Evergreen Provision”), from 2,200,000 shares to 2,950,000 shares. | on January 1st of each year through 2022, automatically increases the number of shares subject to the 2012 Plan by the lesser of: (a) a number equal to 10% of the shares of Common Stock authorized under the 2012 Plan as of the preceding December 31st, or (b) an amount, or no amount, as determined by the Board, but in no event may the number of shares of Common Stock authorized under the 2012 Plan exceed 885,781 and (iii) increase the annual individual award limits under the 2012 Plan to 100,000 shares of Common Stock, subject to adjustment in accordance with the 2012 Plan. Per the above mentioned “evergreen” provision, an additional 50,000 shares were automatically allocated for distribution under the 2012 Plan as of January 1, 2017. | ||||||||||||||||||||
| Omnibus Incentive Compensation Plan 2012 [Member] | Restricted Stock [Member] | ||||||||||||||||||||||
| Number of shares reserved for future issuance | 290,944 | |||||||||||||||||||||
| Number of equity instruments other than options outstanding | 406,564 | |||||||||||||||||||||
| Warrant [Member] | Pro-Rate Option [Member] | ||||||||||||||||||||||
| Number of common stock issued | 2,539,061 | |||||||||||||||||||||
| Warrant exercise price (in dollars per share) | $ 5.25 | |||||||||||||||||||||
| Number of each warrant called | 1 | |||||||||||||||||||||
| Warrant [Member] | Public Offering [Member] | ||||||||||||||||||||||
| Number of common stock issued | 134,000 | 1,675,000 | ||||||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||||||
| Number of common stock issued | 183,814 | |||||||||||||||||||||
| Common Stock [Member] | Public Offering [Member] | ||||||||||||||||||||||
| Number of common stock issued | 1,675,000 | |||||||||||||||||||||
| Maximum [Member] | 2006 Stock Incentive Plan [Member] | ||||||||||||||||||||||
| Common stock exercise price (in dollars per share) | $ 3,300 | |||||||||||||||||||||
| Maximum [Member] | Omnibus Incentive Compensation Plan 2012 [Member] | ||||||||||||||||||||||
| Common stock exercise price (in dollars per share) | $ 600 | |||||||||||||||||||||
| Minimum [Member] | 2006 Stock Incentive Plan [Member] | ||||||||||||||||||||||
| Common stock exercise price (in dollars per share) | $ 2,400 | |||||||||||||||||||||
| Minimum [Member] | Omnibus Incentive Compensation Plan 2012 [Member] | ||||||||||||||||||||||
| Common stock exercise price (in dollars per share) | $ 1.55 | |||||||||||||||||||||
| Underwriters [Member] | Warrant [Member] | 45-day Option Over-Allotment Option [Member] | ||||||||||||||||||||||
| Number of common stock issued | 213,800 | |||||||||||||||||||||
| Mr. Robin L. Smith, M.D [Member] | 2012 Plan [Member] | ||||||||||||||||||||||
| Number of options outstanding | 75,000 | |||||||||||||||||||||
| Common stock exercise price (in dollars per share) | $ 1.55 | |||||||||||||||||||||
| Second Common Stock Purchase Agreement [Member] | Aspire Capital Fund, LLC [Member] | ||||||||||||||||||||||
| Number of common shares purchased | 10,000,000 | |||||||||||||||||||||
| Agreement term | 30 months | |||||||||||||||||||||
| Common stock purchase price (in dollars per share) | $ 0.50 | |||||||||||||||||||||
| Description of purchase notice | Amount equal to 50,000 shares, and the closing sale price of its Common Stock is equal to or greater than $0.50 per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of Common Stock traded on its principal market on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice is generally 95% of the volume-weighted average price for Common Stock traded on its principal market on the VWAP Purchase Date. | |||||||||||||||||||||
| Number of common stock issued | 884,671 | |||||||||||||||||||||
| Proceeds from issuance of private placement | $ 1,900,000 | |||||||||||||||||||||
| Second Common Stock Purchase Agreement [Member] | Aspire Capital Fund, LLC [Member] | Commitment Shares [Member] | ||||||||||||||||||||||
| Number of common shares purchased | 2,500,000 | |||||||||||||||||||||
| Second Common Stock Purchase Agreement [Member] | Aspire Capital Fund, LLC [Member] | Maximum [Member] | ||||||||||||||||||||||
| Number of shares sold per day | 50,000 | |||||||||||||||||||||
| First Common Stock Purchase Agreement [Member] | Aspire Capital Fund, LLC [Member] | ||||||||||||||||||||||
| Number of common shares purchased | 10,000,000 | 1,180,000 | ||||||||||||||||||||
| Agreement term | 30 months | |||||||||||||||||||||
| Common stock purchase price (in dollars per share) | $ 0.50 | $ 2.00 | ||||||||||||||||||||
| Description of purchase notice | Amount equal to 50,000 shares, and the closing sale price of its Common Stock is equal to or greater than $0.50 per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of Common Stock traded on its principal market on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice is generally 95% of the volume-weighted average price for Common Stock traded on its principal market on the VWAP Purchase Date. | |||||||||||||||||||||
| Gross cash proceeds | $ 2,400,000 | |||||||||||||||||||||
| First Common Stock Purchase Agreement [Member] | Aspire Capital Fund, LLC [Member] | Maximum [Member] | ||||||||||||||||||||||
| Number of shares sold per day | 50,000 | |||||||||||||||||||||
| Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member] | ||||||||||||||||||||||
| Annual cash fee | $ 300,000 | 250,000 | ||||||||||||||||||||
| Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member] | Stock Option [Member] | ||||||||||||||||||||||
| Expiration period | 10 years | |||||||||||||||||||||
| Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member] | Omnibus Incentive Compensation Plan 2012 [Member] | Restricted Stock [Member] | ||||||||||||||||||||||
| Number of shares granted under the plan | 25,000 | |||||||||||||||||||||
| Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member] | Omnibus Incentive Compensation Plan 2012 [Member] | Stock Option [Member] | ||||||||||||||||||||||
| Number of stock options granted | 75,000 | |||||||||||||||||||||
| Number of option to purchase granted annual award limits | 50,000 | |||||||||||||||||||||
| Employment Agreement [Member] | Mr. George C. Carpenter, IV [Member] | ||||||||||||||||||||||
| Annual cash fee | $ 270,000 | 206,250 | ||||||||||||||||||||
| Employment Agreement [Member] | Mr. George C. Carpenter, IV [Member] | 2012 Plan [Member] | Restricted Stock [Member] | ||||||||||||||||||||||
| Number of stock options granted | 34,380 | |||||||||||||||||||||
| Advisory Agreement [Member] | Maxim Group LLC [Member] | ||||||||||||||||||||||
| Description of compensation under the agreement | The agreement was 100,000 shares of the Company's Common Stock, payable in one payment of 50,000 shares of Common Stock and five monthly payments of 10,000 shares of Common Stock from April through August 2018. | |||||||||||||||||||||
| Advisory Agreement [Member] | Maxim Group LLC [Member] | General and Administrative [Member] | ||||||||||||||||||||||
| Compensation expense | $ 162,300 | |||||||||||||||||||||